KalVista Pharmaceuticals (KALV) Prepaid Assets (2014 - 2025)
KalVista Pharmaceuticals' (KALV) quarterly Prepaid Assets came in at $1.5 million in Q3 2025, down 52.67% year-on-year from $3.1 million in Q3 2024, and down 92.61% quarter-over-quarter from $19.7 million in Q2 2025.
KalVista Pharmaceuticals (KALV) Prepaid Assets (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals has disclosed Prepaid Assets across 12 years of filings, most recently posting $1.5 million for Q3 2025.
- Prepaid Assets for Q3 2025 came in at $1.5 million, down 52.67% year-over-year; the trailing twelve-month figure through Jul 2025 was $1.5 million (down 52.67% YoY), and the FY2025 annual result was $19.7 million, up 595.02% from the prior year.
- Prepaid Assets came in at $1.5 million for Q3 2025 at KalVista Pharmaceuticals, down from $19.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $19.7 million in Q2 2025 to a low of $1.5 million in Q3 2025.
- The 5-year median for Prepaid Assets is $4.9 million (2021), against an average of $5.8 million.
- Across the five-year window, Prepaid Assets tumbled 80.0% in 2023 and surged 595.02% in 2025, its largest moves.
- KalVista Pharmaceuticals' Prepaid Assets stood at $7.3 million in 2021, then advanced by 22.68% to $8.9 million in 2022, then sank by 80.0% to $1.8 million in 2023, then jumped by 248.68% to $6.2 million in 2024, then plunged by 76.6% to $1.5 million in 2025.
- The last three Prepaid Assets figures came in at $1.5 million (Q3 2025), $19.7 million (Q2 2025), and $6.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 1.46 Mn |
| Apr 30, 2025 | 19.69 Mn |
| Dec 31, 2024 | 6.22 Mn |
| Oct 31, 2024 | 5.41 Mn |
| Jul 31, 2024 | 3.07 Mn |
| Apr 30, 2024 | 2.83 Mn |
| Jan 31, 2024 | 2.96 Mn |
| Oct 31, 2023 | 1.78 Mn |
| Jul 31, 2023 | 2.84 Mn |
| Apr 30, 2023 | 2.58 Mn |
| Jan 31, 2023 | 2.52 Mn |
| Oct 31, 2022 | 8.91 Mn |
| Jul 31, 2022 | 11.08 Mn |
| Apr 30, 2022 | 8.40 Mn |
| Jan 31, 2022 | 8.39 Mn |
| Oct 31, 2021 | 7.27 Mn |
| Jul 31, 2021 | 5.54 Mn |
| Apr 30, 2021 | 4.92 Mn |
| Jan 31, 2021 | 4.60 Mn |
| Oct 31, 2020 | 1.52 Mn |